Bloomberg the Company & Products

Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us

  • Exchange: Frankfurt
  • Sector: Health Care
  • Industry: Biotech & Pharma
  • Sub-Industry: Specialty Pharma

RegeneRx Biopharmaceuticals Inc

+ Add to Watchlist

RRX:GR

0.353 EUR 0.017 5.06%

As of 13:37:20 ET on 04/17/2015.

Snapshot for RegeneRx Biopharmaceuticals Inc (RRX)

Open: 0.347 Day's Range: 0.325 - 0.361 Volume: 0
Previous Close: 0.336 52wk Range: 0.064 - 0.369 1-Yr Rtn: +161.48%

Stock Chart for RRX

No chart data available.
  • RRX:GR 0.353
  • 1D
  • 1M
  • 1Y
0.336
Interactive RRX Chart

Previous Close

No chart data available.
Interactive Chart
  • 1D
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Close:
Open:
High:
Low:
Volume:
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Key Statistics for RRX

Current P/E Ratio (ttm) -
Estimated P/E(-) -
Relative P/E vs. DAX -
Earnings Per Share (ttm) -
Est. EPS -
Est. PEG Ratio -
Market Cap (M EUR) 35.76
Shares Outstanding (M) 101.32
30 Day Average Volume 167
Price/Book (mrq) -
Price/Sale (ttm) -
Dividend Indicated Gross Yield -%
Cash Dividend -
Dividend Ex-Date
5 Year Dividend Growth -
Next Earnings Announcement 05/15/2015
mrq = Most Recent Quarter; ttm = Trailing Twelve Months

Income Statement for RRX

  • Revenue
  • Net Income (M/USD)
  • Profit Margin (%)

Company Profile & Key Executives for RRX

RegeneRx Biopharmaceuticals, Inc. is focusing on the commercialization of Thymosin beta 4, a 43 amino acid peptide. The Company is concentrating its efforts on the use of Thymosin beta 4 for the treatment of injured tissue and non-healing wounds to enable more rapid repair and/or tissue regeneration.

Allan L GoldsteinChairman/Chief Scientific AdvisorJ J FinkelsteinPresident/CEO
Alan KleinInterim Chief Business Officer
More Company Profile & Key Executives for RRX

Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.

Sponsored Link
Advertisement
Advertisement
Sponsored Links
Advertisements
sec ||= nil